188 related articles for article (PubMed ID: 25345606)
1. The roles of neurotensin and its analogues in pain.
Feng YP; Wang J; Dong YL; Wang YY; Li YQ
Curr Pharm Des; 2015; 21(7):840-8. PubMed ID: 25345606
[TBL] [Abstract][Full Text] [Related]
2. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog.
Tétreault P; Besserer-Offroy É; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent AJ; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P
Eur J Pharmacol; 2020 Sep; 882():173174. PubMed ID: 32534076
[TBL] [Abstract][Full Text] [Related]
3. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
Smith KE; Boules M; Williams K; Richelson E
Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
[TBL] [Abstract][Full Text] [Related]
5. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.
Boules M; Johnston H; Tozy J; Smith K; Li Z; Richelson E
Behav Pharmacol; 2011 Sep; 22(5-6):573-81. PubMed ID: 21691202
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
[TBL] [Abstract][Full Text] [Related]
7. Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model.
Roussy G; Dansereau MA; Doré-Savard L; Belleville K; Beaudet N; Richelson E; Sarret P
J Neurochem; 2008 May; 105(4):1100-14. PubMed ID: 18182046
[TBL] [Abstract][Full Text] [Related]
8. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
[TBL] [Abstract][Full Text] [Related]
9. NT69L, a novel analgesic, shows synergy with morphine.
Boules M; Shaw A; Liang Y; Barbut D; Richelson E
Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107
[TBL] [Abstract][Full Text] [Related]
10. Endogenous neurotensin facilitates visceral nociception and is required for stress-induced antinociception in mice and rats.
Gui X; Carraway RE; Dobner PR
Neuroscience; 2004; 126(4):1023-32. PubMed ID: 15207335
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P
Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249
[TBL] [Abstract][Full Text] [Related]
12. Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors.
Sarret P; Esdaile MJ; Perron A; Martinez J; Stroh T; Beaudet A
J Neurosci; 2005 Sep; 25(36):8188-96. PubMed ID: 16148226
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P
Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077
[TBL] [Abstract][Full Text] [Related]
14. Involvement of NTS2 receptors in stress-induced analgesia.
Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
[TBL] [Abstract][Full Text] [Related]
15. Opioid-induced release of neurotensin in the periaqueductal gray matter of freely moving rats.
Stiller CO; Gustafsson H; Fried K; Brodin E
Brain Res; 1997 Nov; 774(1-2):149-58. PubMed ID: 9452203
[TBL] [Abstract][Full Text] [Related]
16. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
[TBL] [Abstract][Full Text] [Related]
17. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
Vivancos M; Fanelli R; Besserer-Offroy É; Beaulieu S; Chartier M; Resua-Rojas M; Mona CE; Previti S; Rémond E; Longpré JM; Cavelier F; Sarret P
Behav Brain Res; 2021 May; 405():113189. PubMed ID: 33607165
[TBL] [Abstract][Full Text] [Related]
18. A mechanism for the analgesic effect of neurotensin as revealed by behavioral and electrophysiological techniques.
Behbehani MM; Pert A
Brain Res; 1984 Dec; 324(1):35-42. PubMed ID: 6518391
[TBL] [Abstract][Full Text] [Related]
19. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
20. The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.
Eiselt E; Côté J; Longpré JM; Blais V; Sarret P; Gendron L
Eur J Pharmacol; 2019 Apr; 848():80-87. PubMed ID: 30707956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
